2-Hydroxysaclofen

From WikiMD's WELLNESSPEDIA

2-Hydroxysaclofen.svg

Chemical compound

2-Hydroxysaclofen































2-Hydroxysaclofen is a chemical compound that acts as a GABA_B receptor antagonist. It is a derivative of saclofen, which is known for its role in the study of neuropharmacology and neuroscience.

Chemical Properties[edit]

2-Hydroxysaclofen has a molecular structure similar to saclofen, with the addition of a hydroxyl group. This modification affects its binding affinity and activity at the GABA_B receptor.

Pharmacology[edit]

As a GABA_B receptor antagonist, 2-Hydroxysaclofen inhibits the action of the neurotransmitter gamma-Aminobutyric acid (GABA) at the GABA_B receptor. This can lead to increased neuronal excitability and has implications for research into epilepsy, pain management, and neurodegenerative diseases.

Research Applications[edit]

2-Hydroxysaclofen is primarily used in research settings to study the function of GABA_B receptors. It helps in understanding the role of these receptors in various physiological and pathological processes. Studies involving 2-Hydroxysaclofen contribute to the development of new therapeutic strategies for conditions such as chronic pain, spasticity, and addiction.

Safety and Handling[edit]

As with many research chemicals, proper safety protocols should be followed when handling 2-Hydroxysaclofen. This includes the use of appropriate personal protective equipment (PPE) and adherence to laboratory safety guidelines.

See Also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.